The evaluation of liver fibrosis regression in chronic hepatitis C patients after the treatment with direct-acting antiviral agents – A review of the literature by Olga H. Orasan, George Ciulei, Sorina C. Coste, Bianca A. Cibu, Adela V. Sitar Taut, Simina F. Tarmure, Iulia O. Pfingstgraf, Teodora G. Alexescu, Ionela E. Popovici, Flaviu Mureșan, Fabian Ovidiu, Vasile Negrean, Angela Cozma

Subjects: Get full text

Evaluation of the risk of developing hepatocellular carcinoma in chronic Hepatitis C patients receiving antiviral treatment by Sona Sargsyan, Hripsime Magdesieva, Tsoghik Navoyan, Aregnaz Mkhitaryan, Lusine Atoyan, Violeta Sargsyan, Hayk Harutyunyan, Vahe Azatyan, Armine Minasyan, Naira Gyulazyan

Subjects: Get full text

Efficacy and safety of sofosbuvir plus daclatasvir in hemodialysis patients with genotype 1b or 2a hepatitis C virus infection: a single-arm, prospective real-world study by Kaili Wang, Hongyu Yao, Xia Zhou, Hongling Liu, Jun Zhao

Subjects: Get full text

Prescription patterns of comedications associated with drug-drug interactions risk in HCV-infected patients undergoing direct-acting antiviral treatment: an analysis of an administ... by Daisuke Nakamoto, Yi Piao, Hajime Mizutani, Ryozo Wakabayashi, Satoshi Otokita, Alice Stead, Candido Hernandez, Masahisa Jinushi

Subjects: Get full text

NS5A replication complex inhibitor daclatasvir in the basis of chronic hepatitis C interferon-free therapy by M. V. Mayevskaya, M. S. Zharkova, V. T. Ivashkin

Subjects: Get full text

Chronic Hepatitis C Infection Treated with Direct-Acting Antiviral Agents and Occurrence/Recurrence of Hepatocellular Carcinoma: Does It Still Matter? by Carlo Smirne, Maria Grazia Crobu, Irene Landi, Nicole Vercellino, Daria Apostolo, David James Pinato, Federica Vincenzi, Rosalba Minisini, Stelvio Tonello, Davide D’Onghia, Antonio Ottobrelli, Silvia Martini, Christian Bracco, Luigi Maria Fenoglio, Mauro Campanini, Alessandro Maria Berton, Alessia Ciancio, Mario Pirisi

Subjects: “…direct-acting antiviral agents…”
Get full text

Liver fibrosis assessment by transient elastography in patients with liver cirrhosis after hepatitis C virus eradication by E. A. Nabatchikova, D. T. Abdurakhmanov, E. N. Nikulkina, T. P. Rozina, E. L. Tanaschuk, S. V. Moiseev

Subjects: Get full text

Are there differences in efficacy and safety between local and imported direct-acting antiviral agents for hepatitis C in China? by Zhitao Wang, Youbing Ran, Yihan Fu, Jing Sun, Yuanli Liu

Subjects: “…Direct-acting antiviral agent…”
Get full text

An ODEs multiscale model with cell proliferation for hepatitis C virus infection treated with direct acting antiviral agents by Hesham A. Elkaranshawy, Hossam M. Ezzat

Subjects: Get full text

Emerging therapies for the treatment of hepatitis C by Christian M Lange, Ira M Jacobson, Charles M Rice, Stefan Zeuzem

Subjects: “…directly acting antiviral agents…”
Get full text